Scope & limitations
The related pain-reversal study concerns SCN9A / Nav1.7-related CIP and does not establish applicability to NTRK1-CIPA. Other claims, including prevalence, remain insufficiently verified; this is not a primary family-care reference.
About these terms
- CIP
- Some resources use CIP (congenital insensitivity to pain) without the “anhidrosis” qualifier. Its scope is broader than CIPA, and this site does not treat the two as equivalent; where a resource is filed under CIP, its relationship to CIPA is stated in that record’s scope note.Based on: This site’s editorial handling (not a medical claim)
Record details
- Source organization
- Rare Disease Hong Kong
- Regions
- China
- Research record date
- 2026-09-21This is not the medical revision date.
- Publication status
- Publication review complete
Title, version & context
- Index title
- Chinese-language CIPA information
- Version & date
- No explicit medical revision date was found.
- Source title
先天性痛覺不敏感症合併無汗症（CIPA）/ 先天性無痛無汗症 （CN）
Congenital Insensitivity to Pain with Anhidrosis (CIPA)
- Relationship to CIPA
- Specifically focused on CIPA.
Reading notes
- Main audience
- Resource researchers locating Chinese-language CIPA pages in Hong Kong.
- Resource purpose
- Use it to see the organization’s CIPA entry and its reference leads. For the medical wording, refer to the source page itself.